DiscoverThe Grenz ZoneEp35 – MISC – HS Part II – Pathogenesis, Comorbidities, & Treatment
Ep35 – MISC – HS Part II – Pathogenesis, Comorbidities, & Treatment

Ep35 – MISC – HS Part II – Pathogenesis, Comorbidities, & Treatment

Update: 2021-07-14
Share

Description

In the second episode of season 3, we continue our three episode series on hidradenitis suppurativa with a discussion of the pathogenesis, comorbidities, and treatment of HS. We break down the complex treatment of HS into five categories including trigger avoidance, topical therapies, systemic oral agents, biologics, and surgery. 





References:





Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76-90. doi:10.1016/j.jaad.2019.02.067





Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91-101. doi:10.1016/j.jaad.2019.02.068





Connect with us:





Facebook   │   Instagram





www.grenzzonederm.com – includes excellent episode study guides!





Feel free to contact us with any feedback through our website or at grenzzonederm@gmail.com





If you enjoy the podcast, please help us out by sharing the episodes with a friend and by leaving a 5-star review.  When he’s up for it, Dr. Grumpypants will read his favorite recent review on our social media accounts, will it be yours? 





Musical support provided by:





        •       Daniel Thompson(bass) 





        •       Alec Tackmann (drums)  





        •       Thomas and the Shakes  





Terms of use:  The views, information, or opinions expressed during this podcast: 1) are for general informational purposes, 2) are solely those of the individuals involved, and 3) do not represent those of Orange Park Medical Center, Olmsted Medical Center, or their affiliates.  By listening to this podcast, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating. Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast. Under no circumstances shall Pearl Podcasting, LLC, any guests or contributors to the podcast, or any employees, independent contractors, associates, or affiliates of Pearl Podcasting, LLC be responsible for damages arising from use of the podcast.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Ep35 – MISC – HS Part II – Pathogenesis, Comorbidities, & Treatment

Ep35 – MISC – HS Part II – Pathogenesis, Comorbidities, & Treatment

Logan Kolb, DO; Karthik Krishnamurthy, DO